Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Apr 1;10(7):1407.
doi: 10.3390/jcm10071407.

Adjunctive Use of Statins for COVID-19

Mike Sathekge  1   2 , Geert Byttebier  3 , Bart De Spiegeleer  4 , Bo Saxberg  5 , Veronica Ueckermann  6 , Luc Belmans  7 , Myriam Alexander  8 , David Fedson  9
Affiliations
Editorial

Adjunctive Use of Statins for COVID-19

Mike Sathekge et al. J Clin Med. .

Abstract

The interaction between obesity, cardiometabolic disorders and COVID-19 represents a syndemic that requires both social intervention and a multipharmacological approach [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Survival within 60 d in severe acute respiratory syndrome coronavirus 2-infected patients and a retrospective cohort of hospitalized pneumonia patients between January and June 2019 (overall cohort). (A) Comparison of statin-treated vs. statin-nontreated coronavirus disease 2019 (COVID-19) patients (adjusted). (B) Comparison of statin-treated vs. statin-nontreated COVID-19 and hospitalized pneumonia patients between January and June 2019 (retrospective cohort, adjusted) [17].
See this image and copyright information in PMC

References

    1. Nägele M.P., Haubner B., Tanner F.C., Ruschitzka F., Flammer A.J. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58–62. doi: 10.1016/j.atherosclerosis.2020.10.014. - DOI - PMC - PubMed
    1. De Spiegeleer A., Bronselaer A., Teo J.T., Byttebier G., De Tré G., Belmans L., Dobson R., Wynendaele E., Van De Wiele C., Vandaele F., et al. The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents. J. Am. Med. Dir. Assoc. 2020;21:909–914.e2. doi: 10.1016/j.jamda.2020.06.018. - DOI - PMC - PubMed
    1. Fedson D.S., Opal S.M., Rordam O.M. Hiding in plain sight: An approach to treating patients with severe COVID-19 infection. mBio. 2020;20:e00398-20. doi: 10.1128/mBio.00398-20. - DOI - PMC - PubMed
    1. Khan A.R., Misdary C., Yegya-Raman N., Kim S., Narayanan N., Siddiqui S., Salgame P., Radbel J., Groote F., Michel C., et al. Montelukast in hospitalized patients diagnosed with COVID-19. J. Asthma. 2021;12:1–13. doi: 10.1080/02770903.2021.1881967. - DOI - PMC - PubMed
    1. Parihar S.P., Guler R., Brombacher F. Statins: A viable candidate for host-directed therapy against infectious diseases. Nat. Rev. Immunol. 2019;19:104–117. doi: 10.1038/s41577-018-0094-3. - DOI - PubMed

Publication types

LinkOut - more resources